Biltmore Family Office LLC Has $2.51 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Biltmore Family Office LLC lowered its position in Aflac Incorporated (NYSE:AFL) by 2.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 24,263 shares of the financial services provider’s stock after selling 500 shares during the period. Biltmore Family Office LLC’s holdings in Aflac were worth $2,510,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in AFL. Norges Bank acquired a new stake in shares of Aflac during the fourth quarter worth about $349,699,000. Raymond James Financial Inc. bought a new stake in Aflac during the 4th quarter worth approximately $163,409,000. Amundi lifted its stake in Aflac by 81.1% in the fourth quarter. Amundi now owns 2,753,513 shares of the financial services provider’s stock valued at $285,181,000 after buying an additional 1,232,683 shares in the last quarter. Vanguard Group Inc. lifted its stake in Aflac by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock valued at $5,310,640,000 after buying an additional 653,275 shares in the last quarter. Finally, Assenagon Asset Management S.A. boosted its holdings in shares of Aflac by 670.9% in the fourth quarter. Assenagon Asset Management S.A. now owns 556,576 shares of the financial services provider’s stock valued at $57,572,000 after buying an additional 484,378 shares during the period. Institutional investors and hedge funds own 67.44% of the company’s stock.

Analyst Upgrades and Downgrades

AFL has been the topic of a number of research analyst reports. Barclays dropped their price objective on shares of Aflac from $98.00 to $95.00 and set an “underweight” rating on the stock in a report on Friday, February 7th. Wells Fargo & Company cut their price target on Aflac from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Wednesday, February 19th. JPMorgan Chase & Co. increased their price objective on Aflac from $94.00 to $96.00 and gave the stock a “neutral” rating in a report on Wednesday. Piper Sandler lifted their target price on Aflac from $118.00 to $124.00 and gave the company an “overweight” rating in a research report on Wednesday. Finally, StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a research report on Friday, February 14th. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $104.29.

Insider Buying and Selling at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of the firm’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the completion of the sale, the director now owns 49,962 shares in the company, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Joseph L. Moskowitz sold 1,000 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the completion of the transaction, the director now owns 25,393 shares in the company, valued at approximately $2,733,048.59. This trade represents a 3.79 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Aflac Stock Down 0.1 %

Aflac stock opened at $112.32 on Thursday. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. The company’s 50-day moving average is $106.87 and its 200-day moving average is $107.74. The firm has a market capitalization of $61.31 billion, a PE ratio of 11.70, a P/E/G ratio of 3.24 and a beta of 0.81. Aflac Incorporated has a fifty-two week low of $79.31 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL) last announced its quarterly earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Sell-side analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.